SCHEMBL14545970

SCHEMBL14545970

Bc1cnn2c(NCCNC(=O)c3ccc4ccccc4c3)cc(-c3ccccc3Cl)nc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 4/20 0.45
▸ CDK2 P24941 4/20 0.45
▸ IDO1 P14902 1/20 0.43
▸ DRD2 P14416 4/20 0.41
▸ DRD3 P35462 4/20 0.41
▸ ADRA1A P35348 3/20 0.41
▸ DRD4 P21917 2/20 0.41
▸ SLC6A4 P31645 2/20 0.40
▸ SLC6A2 P23975 1/20 0.40
▸ HDAC3 O15379 2/20 0.39
▸ HDAC1 Q13547 2/20 0.39
▸ HDAC4 P56524 1/20 0.39
▸ HDAC7 Q8WUI4 1/20 0.39
▸ HDAC2 Q92769 1/20 0.39
▸ HDAC10 Q969S8 1/20 0.39
▸ HDAC11 Q96DB2 1/20 0.39
▸ HDAC8 Q9BY41 1/20 0.39
▸ HDAC6 Q9UBN7 1/20 0.39
▸ HDAC9 Q9UKV0 1/20 0.39
▸ HDAC5 Q9UQL6 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13289231 0.95 DRD2 (0.46) GSK3BCDK2IDO1DRD2DRD3
SCHEMBL13120297 0.89 CDK2 (0.58) GSK3BCDK2IDO1DRD2DRD3
SCHEMBL13288754 0.89 CDK2 (0.45) GSK3BCDK2DRD2DRD3DRD4
SCHEMBL13288882 0.89 CDK2 (0.54) GSK3BCDK2DRD2DRD3HDAC3
SCHEMBL13289275 0.88 HDAC1 (0.42) GSK3BCDK2HDAC3HDAC1HDAC4
SCHEMBL14545832 0.87 CDK2 (0.48) GSK3BCDK2
SCHEMBL13288895 0.87 GSK3B (0.43) GSK3BCDK2CYP1A2CYP2D6CYP2C19
SCHEMBL14545261 0.87 CDK2 (0.53) GSK3BCDK2CYP2C19
SCHEMBL14545971 0.87 NPC1 (0.43) GSK3BCDK2
SCHEMBL13289235 0.86 CDK2 (0.45) GSK3BCDK2DRD2DRD3DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007044449-A2 NOVEL PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS SCHERING CORPORATION (US) 2007-04-19 — — WO disclosed
Send feedback